Found 5 results
Author Title Type [ Year
] Filters: Author is Stadtmauer, Edward A [Clear All Filters]
. 2019. “Autologous Transplantation, Consolidation, And Maintenance Therapy In Multiple Myeloma: Results Of The Bmt Ctn 0702 Trial.”. J Clin Oncol 37 (7). J Clin Oncol: 589-597. doi:10.1200/JCO.18.00685.
. 2013. “Phase Iii Randomized Study Of Rituximab/carmustine, Etoposide, Cytarabine, And Melphalan (Beam) Compared With Iodine-131 Tositumomab/beam With Autologous Hematopoietic Cell Transplantation For Relapsed Diffuse Large B-Cell Lymphoma: Results From The Bmt C”. J Clin Oncol 31 (13). J Clin Oncol: 1662-8. doi:10.1200/JCO.2012.45.9453.
. 2012. “Characteristics Of Clinimacs® System Cd34-Enriched T Cell-Depleted Grafts In A Multicenter Trial For Acute Myeloid Leukemia-Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn) Protocol 0303.”. Biol Blood Marrow Transplant 18 (5). Biol Blood Marrow Transplant: 690-7. doi:10.1016/j.bbmt.2011.08.017.
. 2011. “Autologous Haemopoietic Stem-Cell Transplantation Followed By Allogeneic Or Autologous Haemopoietic Stem-Cell Transplantation In Patients With Multiple Myeloma (Bmt Ctn 0102): A Phase 3 Biological Assignment Trial.”. Lancet Oncol 12 (13). Lancet Oncol: 1195-203. doi:10.1016/S1470-2045(11)70243-1.
. 2010. “Randomized, Double-Blind Trial Of Fluconazole Versus Voriconazole For Prevention Of Invasive Fungal Infection After Allogeneic Hematopoietic Cell Transplantation.”. Blood 116 (24). Blood: 5111-8. doi:10.1182/blood-2010-02-268151.